Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
HOME > COMMENTARY
COMMENTARY
-
Japan's Most Admired Pharma Companies in 2010
April 4, 2011
-
Will New Disclosure GL Promote Industry-Academia Alliances?
March 28, 2011
-
Use of Generics by Welfare Recipients
March 7, 2011
-
Wholesalers' Profits Drop Sharply Putting Premium for New Drug Development in Peril
February 21, 2011
-
Safety Measures Based on Common Medical Knowledge Questioned by Court: Iressa Affair
February 21, 2011
-
Recent Topics in Promising Anticancer Therapeutics
January 17, 2011
-
Development Race for Oral Anticoagulants Entering Final Stretch
October 11, 2010
-
How to Eliminate Concerns about Safety of Liovel
October 4, 2010
-
Will It Be Possible to Eliminate Unnecessary Equivalence Studies for Generics?
September 20, 2010
-
Big Pharma Losing Flagships within a Few Years and Shifting Paradigm
September 13, 2010
-
Prior Assessment System Is One Step Forward to Quicker NDA Review
August 2, 2010
-
Industry Needs to Form Consensus on Premium with Med. Institutions
July 26, 2010
-
Japan Should Promote Personalized Cancer Treatment
July 26, 2010
-
METI Reports on “Patent Box”Taxation System in Its Vision 2010
July 5, 2010
-
How Will Generics-Only Companies Will Compete with Major New Entrants?
June 28, 2010
-
Mr Hasegawa Calls For Cooperation with Asian Countries
June 21, 2010
-
PMDA Consultation for Clinical Drug Development in Japan
April 26, 2010
-
Taiyo Needs to Restart from Scratch
April 19, 2010
-
Drug Companies Have No Time to Lose under New Pricing System
March 29, 2010
-
Wholesalers, Pharmacy Chains to Ally to Improve Their Business
March 22, 2010
